Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Immunotoxicity

Currently viewing:

Administrative data

Description of key information

Data waiving. 

Key value for chemical safety assessment

Effect on immunotoxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed

Effect on immunotoxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Effect on immunotoxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed

Additional information

No evidence of immunotoxic effects have been found in existing oral or dermal repeated dose toxicity studies on structurally related substances following exposures up to 2 years. Moreover, no such reported effects could be identified for this substance class from desktop searches.


Justification for selection of effect on immunotoxicity via oral route endpoint:
No evidence of immunotoxic effects have been found in existing oral repeated dose toxicity studies on structurally related substances following exposures up to 2 years. Moreover, no such reported effects could be identified for this substance class from desktop searches.

Justification for selection of effect on immunotoxicity via dermal route endpoint:
No evidence of immunotoxic effects have been found in existing dermal repeated dose toxicity studies on structurally related substances following exposures up to 2 years. Moreover, no such reported effects could be identified for this substance class from desktop searches.

Justification for classification or non-classification

No evidence of immunotoxic effects have been found in existing oral or dermal repeated dose toxicity studies on structurally related substances with exposures up to 2 years. Moreover, no such reported effects could be identified for this substance class from desktop searches.